Cargando…
Glutaminolysis Mediated by MALT1 Protease Activity Facilitates PD-L1 Expression on ABC-DLBCL Cells and Contributes to Their Immune Evasion
Previous studies have demonstrated that programmed death-1 ligand 1 (PD-L1) expressed in an aggressive activated B-cell (ABC)/non-germinal center B cell–like (GCB) subtype of diffuse large B-cell lymphoma (DLBCL) is associated with inhibition of the tumor-associated T cell response. However, the mol...
Autores principales: | Xia, Xichun, Zhou, Wei, Guo, Chengbin, Fu, Zhen, Zhu, Leqing, Li, Peng, Xu, Yan, Zheng, Liangyan, Zhang, Hua, Shan, Changliang, Gao, Yunfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305595/ https://www.ncbi.nlm.nih.gov/pubmed/30619766 http://dx.doi.org/10.3389/fonc.2018.00632 |
Ejemplares similares
-
Attacking MALT1 for ABC-DLBCL therapy
por: Krappmann, Daniel
Publicado: (2012) -
MALT1 protease activity in primary effusion lymphoma
por: Juilland, Mélanie, et al.
Publicado: (2017) -
Glutaminolysis feeds mTORC1
por: Durán, Raúl V., et al.
Publicado: (2012) -
Combining precision oncology and immunotherapy by targeting the MALT1 protease
por: Mempel, Thorsten R, et al.
Publicado: (2022) -
IGFBP3 Enhances Treatment Outcome and Predicts Favorable Prognosis in ABC-DLBCL
por: Li, Han-Bing, et al.
Publicado: (2023)